Collagen and Kidney Stones: Hydroxyproline & Oxalate

Collagen and gelatin are rich in hydroxyproline, which can be metabolised to oxalate after absorption. Human studies show that sufficiently large gelatin or free-hydroxyproline loads can raise urinary oxalate, but they do not show that ordinary collagen doses cause kidney stones. People with recurrent calcium-oxalate stones or disorders of oxalate metabolism should discuss regular collagen use with their clinician.

Why does collagen affect oxalate at all?

Roughly 13% of hydrolysed collagen by weight is hydroxyproline, an amino acid found almost nowhere else in the diet outside collagen and gelatin. In the liver, hydroxyproline is broken down through a pathway that produces glyoxylate as an intermediate step. Glyoxylate has two possible fates: the body converts most of it safely into glycine, but a portion is oxidised into oxalate instead. Oxalate itself has no biological function — it's simply excreted in urine, where it can bind with calcium to form crystals. In most people, adequate urine volume and citrate keep those crystals microscopic and harmless. In susceptible people, the balance tips toward stone formation.

What does the direct human evidence show?

In a controlled feeding study, 10 participants consumed 30 g/day of gelatin or whey on matched diets. Gelatin increased 24-hour urinary oxalate by 43% and urinary glycolate more than five-fold relative to whey. The same paper also tested 5 g and 10 g gelatin challenges and found measurable changes in hydroxyproline-related metabolism [1]. This demonstrates the pathway in humans, but it used gelatin rather than a defined modern collagen peptide and did not measure kidney-stone events.

A separate 12-week dose-ranging trial gave healthy adults 0, 500, 1,000 or 2,000 mg/day of isolated L-hydroxyproline. Urinary oxalate increased at weeks 8 and 12 in the 2,000 mg/day group, but not at the lower doses [2]. Free hydroxyproline is not pharmacokinetically identical to peptide-bound hydroxyproline in collagen, and the study was small, manufacturer-funded and conducted in healthy volunteers rather than stone-formers.

Together, these studies support biological plausibility and dose caution. They do not establish the stone risk of 5–10 g/day hydrolysed collagen, and they should not be converted into a precise probability of forming a stone.

Who is actually at risk?

"Kidney stones" isn't one condition — several different stone types exist, and the oxalate mechanism only applies to one of them.

Calcium-oxalate stones — where this matters

This is the most common stone type in adults. If you've had a calcium-oxalate stone before, or have a family history of them, this is the population where the collagen-oxalate question is worth a real conversation with your nephrologist, particularly if you also have low urine output, low urinary citrate, or a history of recurrent stones.

Where it doesn't apply

Uric acid stones form because of persistently acidic urine, often linked to gout, diabetes, or obesity — a different mechanism entirely, unrelated to oxalate. Cystine stones come from an inherited transport disorder. Struvite ("infection") stones form during urinary tract infections with specific bacteria. Calcium phosphate stones relate to acid-base handling in the kidney. None of these are driven by dietary oxalate, so collagen's hydroxyproline content isn't a specific concern for any of them. If you don't know your stone type, your urologist or nephrologist can usually tell you from a passed stone analysis or urine chemistry.

Does taking collagen with calcium neutralise the oxalate issue?

No evidence shows that taking calcium with collagen prevents hydroxyproline-derived oxalate. Dietary calcium can bind dietary oxalate in the intestinal lumen before that oxalate is absorbed. Collagen's concern is different: hydroxyproline can be absorbed first and then metabolised inside the body to glyoxylate and oxalate. Maintaining an appropriate dietary calcium intake is part of standard stone-prevention advice for many calcium-oxalate stone-formers, but it should not be presented as an antidote to collagen-derived oxalate.

Practical steps if you're a stone-former and want to continue

If you have recurrent calcium-oxalate stones, hyperoxaluria, primary hyperoxaluria, advanced kidney disease, or an unexplained high urinary oxalate level, discuss collagen with your nephrologist or urologist before using it regularly. Hydration and a clinician-directed stone-prevention diet matter more than supplement timing. In selected recurrent stone-formers, a 24-hour urine collection before and after a meaningful diet or supplement change can show whether urinary oxalate changes in that individual. There is not enough evidence to prescribe a universally 'safe' collagen dose for stone-formers.

A joint-only alternative that sidesteps the concern entirely

If your only goal is joint comfort, undenatured type II collagen (UC-II) is worth knowing about. It's a completely different product — roughly 40 mg per day rather than 5–10 g, working through a different proposed mechanism (oral tolerance) rather than the peptide-signalling route hydrolysed collagen uses. In a 180-day trial of adults with knee osteoarthritis, 40 mg/day of UC-II significantly improved WOMAC pain, stiffness and function scores compared with both placebo and a glucosamine-chondroitin comparator [3]. At that dose scale, the hydroxyproline contribution is negligible, making it a reasonable alternative for stone-formers whose main interest is joints specifically — though it's worth noting two of that trial's three authors were employees of the product's manufacturer, a disclosed conflict worth weighing.

What we still don't know

No long-term trial has randomized calcium-oxalate stone-formers to ordinary hydrolysed-collagen doses and measured stone recurrence. We also do not know whether marine, bovine and porcine hydrolysates differ meaningfully in hydroxyproline-derived oxalate production at matched doses, or whether peptide-bound hydroxyproline behaves exactly like the isolated amino acid used in dose-ranging work.

Related reading: collagen side effects, dose evidence, and the complete HCP guide.

Bottom line

Hydroxyproline metabolism makes the collagen–oxalate concern biologically real: direct human studies show that high gelatin or free-hydroxyproline exposure can increase urinary oxalate [1] [2]. What remains unknown is whether normal hydrolysed-collagen doses materially increase actual stone recurrence. Healthy people should not infer that collagen causes stones; recurrent calcium-oxalate stone-formers should individualise the decision with their clinical team. See our safety guide for the broader picture.